RANDOMIZED TRIAL OF INTRAVITREAL BEVACIZUMAB ALONE OR COMBINED WITH TRIAMCINOLONE VERSUS MACULAR PHOTOCOAGULATION IN DIABETIC MACULAR EDEMA

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

OBUDI A.; RAMEZANI A.R.; SALEHIPOUR M.; ROSTAMI P.; YASERI M.; SOHEILIAN M.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: BINA Year:2011 | Volume:16 | Issue:3 (64) Page(s): 226-238

Download Full-Text

Persian Verion

View:

7,275

Download:

Cites:

Information Journal Paper

Title

RANDOMIZED TRIAL OF INTRAVITREAL BEVACIZUMAB ALONE OR COMBINED WITH TRIAMCINOLONE VERSUS MACULAR PHOTOCOAGULATION IN DIABETIC MACULAR EDEMA

Author(s)

Keywords

BEVACIZUMABQ3

TRIAMCINOLONEQ3

PHOTOCOAGULATIONQ3

MACULAR EDEMAQ3

Abstract

Purpose: To compare the results of intravitreal bevacizumb (NB) injection alone or in combination with intravitreal TRIAMCINOLONE acetonide (IVT) versus macular laser PHOTOCOAGULATION (MPC) as primary treatment of diabetic MACULAR EDEMA (DME).Methods: In this randomized clinical trial, 150 eyes of 129 patients with clinical DME and no previous treatment were enrolled. The eyes were randomly assigned to one of the three study arms: the IVB group received 1.25 mg IVB (50 eyes); the IVB/IVT group received 1.25mg of IVB and 2 mg of IVT (50 eyes); and the MPC group underwent focal or modified grid laser (50 eyes). Retreatment was performed at 12-week intervals whenever indicated.Results: Visual acuity (VA) changes among the groups were statistically significant at 6 (P<0.001) and 24 (p=0.012) weeks. VA change was significant only in the IVB group at 12 weeks. VA changes±standard deviation at 36 weeks were -0.28±0.25, -0.04±0.33, and+0.01±0.27 LogMAR in the NB, NB/IVT, and MPC groups, respectively (P=0.053). Significant reduction in central macular thickness (CMT) was observed in all groups only up to 6 weeks; however, CMT changes were not significantly different among the groups in all visits. Overall, retreatment was required for 27 eyes up to 36 weeks (14 in the IVB group, 10 in the IVB/IVT group, and 3 in the MPC group). In the IVB group, in which greater VA improvement was observed, only one injection was required in 72% of the cases. VA improvement more than 2 Snellen lines at 36 weeks occurred in 37%, 25%, and 14.8% of patients in the NB, IVB/IVT and MPC groups, respectively.Conclusions: Intravitreal BEVACIZUMAB injection in patients with DME yielded a better visual outcome at 24 weeks compared with macular PHOTOCOAGULATION. After 6 weeks changes in CMT and VA were not compatible. No adjunctive effect of IVT was demonstrated.

Multimedia

No record.

Cites

No record.

References

No record.

Cite

APA: Copy

OBUDI, A., RAMEZANI, A.R., SALEHIPOUR, M., ROSTAMI, P., YASERI, M., & SOHEILIAN, M.. (2011). RANDOMIZED TRIAL OF INTRAVITREAL BEVACIZUMAB ALONE OR COMBINED WITH TRIAMCINOLONE VERSUS MACULAR PHOTOCOAGULATION IN DIABETIC MACULAR EDEMA. BINA, 16(3 (64)), 226-238. SID. https://sid.ir/paper/43043/en

Vancouver: Copy

OBUDI A., RAMEZANI A.R., SALEHIPOUR M., ROSTAMI P., YASERI M., SOHEILIAN M.. RANDOMIZED TRIAL OF INTRAVITREAL BEVACIZUMAB ALONE OR COMBINED WITH TRIAMCINOLONE VERSUS MACULAR PHOTOCOAGULATION IN DIABETIC MACULAR EDEMA. BINA[Internet]. 2011;16(3 (64)):226-238. Available from: https://sid.ir/paper/43043/en

IEEE: Copy

A. OBUDI, A.R. RAMEZANI, M. SALEHIPOUR, P. ROSTAMI, M. YASERI, and M. SOHEILIAN, “RANDOMIZED TRIAL OF INTRAVITREAL BEVACIZUMAB ALONE OR COMBINED WITH TRIAMCINOLONE VERSUS MACULAR PHOTOCOAGULATION IN DIABETIC MACULAR EDEMA,” BINA, vol. 16, no. 3 (64), pp. 226–238, 2011, [Online]. Available: https://sid.ir/paper/43043/en

Related Journal Papers